Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...

Adverse genetic mutations can cause harm and are due to various circumstances. "Jumping genes" are one cause of mutations, ...

HCoV-HKU1, which spreads through respiratory droplets, is less severe than SARS or COVID-19. Experts suggested preventive ...